Rankings
▼
Calendar
INDV Q1 2022 Earnings — Indivior Pharmaceuticals Inc Revenue & Financial Results | Market Cap Arena
INDV
Indivior Pharmaceuticals Inc
$4B
Q1 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$207M
Gross Profit
$170M
82.1% margin
Operating Income
$54M
26.1% margin
Net Income
$41M
19.8% margin
EPS (Diluted)
$0.27
QoQ Revenue Growth
-7.2%
Cash Flow
Operating Cash Flow
-$75M
Free Cash Flow
-$75M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$1.7B
Total Liabilities
$1.5B
Stockholders' Equity
$232M
Cash & Equivalents
$874M
← FY 2022
All Quarters
Q2 2022 →
